CTI Plans Label Expansion For Zevalin After Acquiring The NHL Drug From Biogen
Cell Therapeutics intends to initiate clinical studies to expand use of the drug into front-line lymphoma settings.
Cell Therapeutics intends to initiate clinical studies to expand use of the drug into front-line lymphoma settings.